Press Release Johnson & Johnson’s RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer Johnson & Johnson · Jul 30
Press Release MAINGEAR Unveils Next-Gen ‘Zero’ Gaming Desktop PCs: Engineered for Unrelenting Performance, Designed for Unobstructed Visibility MAINGEAR · Jul 30
Press Release C4® Expands Beyond Energy Drinks with the Launch of Sparkling Protein Nutrabolt · Jul 30
Press Release Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson’s Disease Aspen Neuroscience, Inc. · Jul 30
Press Release Nomad Foods to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 Nomad Foods Limited · Jul 30
Press Release Beauty Creations Lands at CVS Pharmacy, Marking Its Biggest Retail Milestone Yet Beauty Creations Cosmetics · Jul 30
Press Release New Clinical Research Presented at NUTRITION 2026 Shows Superbrewed Food’s Postbiotic Cultured Protein Matches Whey in Muscle-Building Response Superbrewed Food Inc. · Jul 30
Press Release Health-E Commerce® Expands Beyond E-Commerce with Launch of Patiently™ Telehealth Platform Offering Personalized, FSA/HSA Eligible Weight Loss and Menopause Support Health-E Commerce · Jul 30
Press Release Lokam.ai Accelerates U.S. Expansion with New Sales Director, Growing Dealership Roster, and Industry-First QoreAI Partnership Lokam.ai · Jul 30
Press Release Lydian Raises $43 Million Series A led by Breakthrough Energy Ventures to Deliver Cost-Competitive Synthetic Aviation Fuel at Commercial Scale Lydian · Jul 30
Press Release Rocket One and NASA Reach Agreement to Advance Space AI Technology Rocket One Inc. · Jul 30